The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)
Coronary interventions
Impact of bivalirudin on post-procedural epicardial blood flow, risk of stent thrombosis and mortality after percutaneous coronary intervention
EuroIntervention 2016;11:e1275-e1282 published online e-edition February 2016. DOI: 10.4244/EIJV11I11A249
K. Anette Fiedler1*, MD; Gjin Ndrepepa1, MD; Stefanie Schulz1, MD; Simone Floh1; Petra Hoppmann2, MD; Sebastian Kufner1, MD; Isabell Bernlochner2, MD; Robert A. Byrne1, MB, BCh, PhD; Heribert Schunkert1,3, MD; Karl-Ludwig Laugwitz2,3, MD; Adnan Kastrati1,3, MD
1. Deutsches Herzzentrum, Technische Universität, Munich, Germany; 2. Medizinische Klinik, Klinikum rechts der Isar, Technische Universität, Munich, Germany; 3. DZHK (German Centre for Cardiovascular Research), partner site Munich Heart Alliance, Munich,
Aims: We aimed to assess the association of bivalirudin with post-procedural Thrombolysis In Myocardial Infarction (TIMI) flow, acute (≤24 hours) and 30-day stent thrombosis (ST), and one